Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Cleveland BioLabs Inc. (CBLI)

2.08   -0.03 (-1.42%) 02-14 16:00
Open: 2.06 Pre. Close: 2.11
High: 2.1103 Low: 2.01
Volume: 259,696 Market Cap: 24M
Cleveland BioLabs Inc is a biopharmaceutical company developing novel approaches to activate immune system & address medical needs. Its proprietary platform of toll-like immune receptor activators are used in radiation, oncology immunotherapy & vaccine.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.456 - 2.468 2.468 - 2.478
Low: 1.982 - 1.996 1.996 - 2.007
Close: 2.06 - 2.082 2.082 - 2.099

Technical analysis

as of: 2020-02-14 4:27:16 PM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 3.81     One year: 5.72
Support: Support1: 0.61    Support2: 0.51
Resistance: Resistance1: 3.26    Resistance2: 4.90
Pivot: 2.62
Moving Average: MA(5): 2.11     MA(20): 2.25
MA(100): 1.05     MA(250): 1.31
MACD: MACD(12,26): 0.26     Signal(9): 0.38
Stochastic oscillator: %K(14,3): 19.37     %D(3): 25.65
RSI: RSI(14): 51.59
52-week: High: 4.90  Low: 0.50  Change(%): 44.4
Average Vol(K): 3-Month: 74938  10-Days: 83857

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
CBLI has closed above bottom band by 30.2%. Bollinger Bands are 213.4% wider than normal. The large width of the bands suggest high volatility as compared to CBLI's normal range. The bands have been in this wide range for 21 bars. This is a sign that the current trend might continue.

Headline News

2020-01-28
The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on Jan. 27) 10X Genomics Inc (NASDAQ: TXG ) Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN )(announced early termination of waiting period for its proposed acquisition by Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN )) Cidara Therapeutics Inc (NASDAQ: CDTX ) Cleveland BioLabs, Inc. (NASDAQ: CBLI )(saw a coronavirus-induced rally ) Denali Therapeutics Inc (NASDAQ: DNLI ) Dr.Reddy's Laboratories Ltd (NYSE: RDY )(reacted to its Q3 results) Inovio Pharmaceuticals Inc (NASDAQ: INO )(announced Nevro Corp (NYSE: NVRO ) Oyster Point Pharma Inc (NASDAQ: OYST ) Quest Diagnostics Inc (NYSE: DGX ) Rapt Therapeutics Inc (NASDAQ: RAPT ) SI-Bone Inc (NASDAQ: SIBN ) Vaccinex Inc (NASDAQ: VCNX ) Vir Biotechnology Inc (NASDAQ: VIR ) Down In The Dumps (Biotech Stocks Hitting 52-week lows on Jan. 27) Alkermes Plc (NASDAQ: ALKS ) Allogene Therapeutics Inc (NASDAQ: ALLO ) Autolus Therapeutics Ltd – ADR (NASDAQ: AUTL ) Axovant Gene Therapies Ltd (NASDAQ: AXGT ) Avanos Medical Inc (NYSE: AVNS ) Blueprint Medicines Corp (NASDAQ: BPMC ) Correvio Pharma Corp (NASDAQ: CORV ) Enanta Pharmaceuticals Inc (NASDAQ: ENTA ) Heat Biologics Inc (NASDAQ: HTBX ) HTG Molecular Diagnostics Inc (NASDAQ: HTGM ) Kura Oncology Inc (NASDAQ: KURA ) Madrigal Pharmaceuticals Inc (NASDAQ: MDGL ) MediciNova, Inc.

2020-01-27
Coronavirus Link Sends This Nano-Cap Stock Up 150%
Shares of nano-cap Cleveland BioLabs, Inc. (NASDAQ: CBLI ) jumped out of the gate at Monday's open and are sustaining the strong momentum on over 100 times their average volume. The strong move came amid a lack of any significant news from the company. It's apparently in reaction to the coronavirus outbreak in China , which has thus far claimed 80 lives and left about 461 in critical condition. Cleveland BioLabs neither has any coronavirus drug or vaccine in its pipeline nor an experimental one targeting the deadly disease. The company's most … Full story available on Benzinga.com

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Capital Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 11.30
Shares Float (M) 3.96
% Held by Insiders 64.99
% Held by Institutions 4.01
Shares Short (K) 70
Shares Short P. Month (K)

Stock Financials

EPS -0.210
Book Value (p.s.) -0.300
PEG Ratio
Profit Margin -241.94
Operating Margin -276.28
Return on Assets (ttm) -42.7
Return on Equity (ttm) -84.8
Qtrly Rev. Growth -4.8
Gross Profit (p.s.) -0.219
Sales Per Share
EBITDA (p.s.) -0.238
Qtrly Earnings Growth
Operating Cash Flow (M) -3.47
Levered Free Cash Flow (M) -2.69

Stock Valuations

P/E -9.90
P/E Growth Ratio -0.01
P/BV -6.93
P/S 23.11
P/CF -6.77

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2015-01-27
Last Split Ratio 0.05
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.